Please Wait.....
Report
Global mRNA Technology Market: Investment & Growth Opportunity Analysis, 2019-2028
Market Report I 2022-09-01 I 120 Pages I RationalStat
Global mRNA Technology Market Analysis and Forecast 2020-2030
Market Introduction
The global mRNA technology market is expected to exhibit a marginal growth rate of 1.8% during the forecast period of 2022-2030. One of the major factors driving the market growth is the increased prevalence of medical disorders such as diabetes, tuberculosis (TB), cancer, and cardiovascular diseases (CVDs). The industry is also benefiting from the rising demand for therapeutic drugs and vaccines for COVID-19, Ebola, influenza, infectious and chronic diseases such as HIV, and other viral illnesses. The recent COVID-19 outbreak has been a launching year for the mRNA technology platforms with the extensive use of mRNA vaccines for treating COVID-19. The market has observed skyrocketed sales of COVID-19 mRNA vaccines during 2020 and 2021. Moreover, the fact that mRNA vaccines hold much more potential than current prophylactic COVID-19 vaccines coupled with the soaring investments in the development of mRNA-based technologies and the perception that COVID-19 will continue to affect the global population, the market for mRNA technologies is expected to witness a steady decline in the few upcoming years.
Market Segmentation
The rise in the prevalence of cancer is expected to provide significant growth opportunities for the market during the forecast period. For instance, according to the World Health Organization (WHO), cancer is one of the leading causes of mortalities globally which accounted for around 10 million mortalities in 2020. Cancer-causing infections such as hepatitis and human papillomavirus are responsible for 30% of cancer cases in low and lower-middle-income countries. Moreover in 2021, according to the National Center for Health Statistics, 1,896,180 new cases cancer cases and 608,570 cancer mortalities were recorded in the US.
Market Structure and Competitive Landscape
The global mRNA technology market is competitive and consists of a number of global and regional players operating in the market. Pharmaceutical companies are investing in mRNA technology as it allows them to mix numerous molecules into a therapeutic drug, which is another important growth factor. The major companies in the market include Moderna Therapeutics, BioNTech, Ethris, CureVac, Argos Therapeutics, Sangamo Therapeutics Inc., Pfizer Inc, Biocon, Tiba Biotechnology, Verve Therapeutics Ltd. and many more. Diversified portfolios of leading firms in innovations and R&D activities characterize the global market, and they are likely to prioritize mergers and acquisitions, and collaborations. Recent developments observed in the market include,
- In June 2022, Pfizer Inc. announced to invest US$ 120 million in its Kalamazoo, Michigan, facility, enabling U.S.-based production in support of its COVID-19 oral treatment, PAXLOVIDTM (nirmatrelvir tablets and ritonavir tablets).
- In January 2022, Pfizer Inc. and BioNTech SE announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring, and painful disease. The collaboration builds on the companies' success in developing the first approved and most widely used mRNA vaccine to help prevent COVID-19.
Global mRNA Technology Market Analysis and Forecast 2020-2030
Table of Contents
1. Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation
2. Assumptions and Acronyms
3. Executive Summary
3.1. Global Market in 2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
4. Research Methodology
5. Analysis of COVID-19 Impact and Road Ahead
5.1. Impact on Growth Strategies
5.2. Impact on Operations and Supply Chain
5.3. Impact on Roll-outs Plans
6. Market Indicators and Background
6.1. Macro-Economic Factors
6.2. Forecasting Factors
Robust assessment of various factors including industrial performance, industry players' expenditures, and economic conditions, among others
6.3. Supply Chain & Value Chain Analysis
6.3.1. mRNA Technology Providers
6.3.2. Key End User
6.4. Industry SWOT Analysis
6.5. PESTLE Analysis
6.6. Porter's Five Forces Analysis
7. Rules & Regulations
8. Global and Regional Market Dynamics
8.1. Drivers
8.2. Restraints
8.3. Trends
8.4. Opportunities
9. Global mRNA Technology Industry: Key Investment and Development Analysis
9.1. By Leading Providers
9.2. By Region
9.3. By Product
9.4. By Application
9.5. M&A Activities
Robust assessment of major investments made by various industry players along with key application areas, and key regions
10. Market Spending & Use Case Analysis
11. Product/Drug Pipeline Analysis
11.1. By Key Players
11.2. By Product
11.3. By Application
11.4. By Region
12. Clinical Trials Analysis
Exhaustive list of all the clinical trials sponsored by various industry players based on the technology will be provided. Moreover, it would also categorize the trials into IND submissions, Phase I, Phase II etc.
13. Parent Market Overview: Global Healthcare & Life Sciences Market
14. Segmental Analysis
14.1. Global mRNA Technology Market by Product
14.1.1. Segment Overview
14.1.1.1. Prophylactic Vaccines
14.1.1.2. Therapeutic Vaccines
14.1.1.3. Therapeutics
14.2. Global mRNA Technology Market by Manufacturing
14.2.1. Segment Overview
14.2.1.1. In-House
14.2.1.2. Outsourced
14.3. Global mRNA Technology Market by Application
14.3.1. Segmental Overview
14.3.1.1. Oncology
14.3.1.2. Respiratory Diseases
14.3.1.3. Infectious Diseases
14.3.1.4. Rare Diseases
14.3.1.5. Others (Coronary Artery Diseases etc.)
14.4. Global mRNA Technology Market by End User
14.4.1. Segment Overview
14.4.1.1. Hospitals and Clinics
14.4.1.2. Academic & Research Institutions
14.5. Global mRNA Technology Market by Region
14.5.1. Segment Overview
14.5.1.1. North America
14.5.1.2. Latin America
14.5.1.3. Western Europe
14.5.1.4. Eastern Europe
14.5.1.5. Asia Pacific
14.5.1.6. Middle East & Africa
15. Regional Analysis
15.1. North America mRNA Technology Market Analysis and Forecast 2020-2030
15.1.1. Regional Market Overview and Key Takeaways
15.1.2. North America mRNA Technology Market by Product
15.1.3. North America mRNA Technology Market by Manufacturing
15.1.4. North America mRNA Technology Market by Application
15.1.5. North America mRNA Technology Market by End User
15.1.6. North America mRNA Technology Market by Country
15.1.6.1. US
15.1.6.2. Canada
15.2. Latin America mRNA Technology Market Analysis and Forecast 2020-2030
15.2.1. Regional Market Overview and Key Takeaways
15.2.2. Latin America mRNA Technology Market by Product
15.2.3. Latin America mRNA Technology Market by Manufacturing
15.2.4. Latin America mRNA Technology Market by Application
15.2.5. Latin America mRNA Technology Market by End User
15.2.6. Latin America mRNA Technology Market by Country
15.2.6.1. Brazil
15.2.6.2. Mexico
15.2.6.3. Rest of Latin America
15.3. Western Europe mRNA Technology Market Analysis and Forecast 2020-2030
15.3.1. Regional Market Overview and Key Takeaways
15.3.2. Western Europe mRNA Technology Market by Product
15.3.3. Western Europe mRNA Technology Market by Manufacturing
15.3.4. Western Europe mRNA Technology Market by Application
15.3.5. Western Europe mRNA Technology Market by End User
15.3.6. Western Europe mRNA Technology Market by Country
15.3.6.1. Germany
15.3.6.2. UK
15.3.6.3. France
15.3.6.4. Spain
15.3.6.5. Italy
15.3.6.6. Benelux
15.3.6.7. Nordic
15.3.6.8. Rest of Western Europe
15.4. Eastern Europe mRNA Technology Market Analysis and Forecast 2020-2030
15.4.1. Regional Market Overview and Key Takeaways
15.4.2. Eastern Europe mRNA Technology Market by Product
15.4.3. Eastern Europe mRNA Technology Market by Manufacturing
15.4.4. Eastern Europe mRNA Technology Market by Application
15.4.5. Eastern Europe mRNA Technology Market by End User
15.4.6. Eastern Europe mRNA Technology Market by Country
15.4.6.1. Russia
15.4.6.2. Poland
15.4.6.3. Rest of Eastern Europe
15.5. Asia Pacific mRNA Technology Market Analysis and Forecast 2020-2030
15.5.1. Regional Market Overview and Key Takeaways
15.5.2. Asia Pacific mRNA Technology Market by Product
15.5.3. Asia Pacific mRNA Technology Market by Manufacturing
15.5.4. Asia Pacific mRNA Technology Market by Application
15.5.5. Asia Pacific mRNA Technology Market by End User
15.5.6. Asia Pacific mRNA Technology Market by Country
15.5.6.1. China
15.5.6.2. Japan
15.5.6.3. India
15.5.6.4. South Korea
15.5.6.5. Australia
15.5.6.6. ASEAN
15.5.6.7. Rest of Asia-Pacific
15.6. Middle East & Africa mRNA Technology Market Analysis and Forecast 2020-2030
15.6.1. Regional Market Overview and Key Takeaways
15.6.2. Middle East & Africa mRNA Technology Market by Product
15.6.3. Middle East & Africa mRNA Technology Market by Manufacturing
15.6.4. Middle East & Africa mRNA Technology Market by Application
15.6.5. Middle East & Africa mRNA Technology Market by End User
15.6.6. Middle East & Africa mRNA Technology Market by Country
15.6.6.1. GCC
15.6.6.2. South Africa
15.6.6.3. Turkey
15.6.6.4. Rest of the Middle East & Africa
16. Competitive Landscape
16.1. Competition Dashboard
16.1.1. Global and Regional Market Share Analysis
16.1.2. Market Structure
16.2. Competitive Benchmarking
16.3. Key Strategy Analysis
16.4. Company Profiles
16.4.1. Moderna Therapeutics
16.4.1.1. Company Overview
16.4.1.2. Product/Service Offerings
16.4.1.3. Key Financials
16.4.1.4. Recent Developments
16.4.2. BioNTech SE
16.4.2.1. Company Overview
16.4.2.2. Product/Service Offerings
16.4.2.3. Key Financials
16.4.2.4. Recent Developments
16.4.3. Ethris GmbH
16.4.3.1. Company Overview
16.4.3.2. Product/Service Offerings
16.4.3.3. Key Financials
16.4.3.4. Recent Developments
16.4.4. AstraZeneca Plc
16.4.4.1. Company Overview
16.4.4.2. Product/Service Offerings
16.4.4.3. Financials
16.4.4.4. Recent Developments
16.4.5. CureVac AG
16.4.5.1. Company Overview
16.4.5.2. Product/Service Offerings
16.4.5.3. Financials
16.4.5.4. Recent Developments
16.4.6. Argos Therapeutics, Inc.
16.4.6.1. Company Overview
16.4.6.2. Product/Service Offerings
16.4.6.3. Financials
16.4.6.4. Recent Developments
16.4.7. Sangamo Therapeutics Inc.
16.4.7.1. Company Overview
16.4.7.2. Product/Service Offerings
16.4.7.3. Financials
16.4.7.4. Recent Developments
16.4.8. Pfizer Inc.
16.4.8.1. Company Overview
16.4.8.2. Product/Service Offerings
16.4.8.3. Financials
16.4.8.4. Recent Developments
16.4.9. Biocon Ltd.
16.4.9.1. Company Overview
16.4.9.2. Product/Service Offerings
16.4.9.3. Financials
16.4.9.4. Recent Developments
16.4.10. Tiba Biotechnology
16.4.10.1. Company Overview
16.4.10.2. Product/Service Offerings
16.4.10.3. Financials
16.4.10.4. Recent Developments
16.4.11. Verve Therapeutics Inc.
16.4.11.1. Company Overview
16.4.11.2. Product/Service Offerings
16.4.11.3. Financials
16.4.11.4. Recent Developments
16.4.12. Takeda Pharmaceutical Co, Ltd.
16.4.12.1. Company Overview
16.4.12.2. Product/Service Offerings
16.4.12.3. Financials
16.4.12.4. Recent Developments
16.4.13. Intellia Therapeutics Inc.
16.4.13.1. Company Overview
16.4.13.2. Product/Service Offerings
16.4.13.3. Financials
16.4.13.4. Recent Developments
16.4.14. Kernal Biologics Inc.
16.4.14.1. Company Overview
16.4.14.2. Product/Service Offerings
16.4.14.3. Financials
16.4.14.4. Recent Developments
*List not exhaustive (Players can be added or replaced as per the customization)
17. Disclaimer
List of Figures
Figure 01: Global mRNA Technology Market Value Analysis (US$ Mn), 2019-2021
Figure 02: Global mRNA Technology Market Size (US$ Mn) & Y-o-Y Growth (%) Analysis, 2022-2028
Figure 03: Global mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 04: Global mRNA Technology Market Y-o-Y Analysis (%) by Product, 2022-2028
Figure 05: Global mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 06: Global mRNA Technology Market Y-o-Y Analysis (%) by Manufacturing, 2022-2028
Figure 07: Global mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 08: Global mRNA Technology Market Y-o-Y Analysis (%) by Application, 2022-2028
Figure 09: Global mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 10: Global mRNA Technology Market Y-o-Y Analysis (%) by End User, 2022-2028
Figure 11: Global mRNA Technology Market Size and Market Share Analysis (%) by region, 2022 & 2028
Figure 12: Global mRNA Technology Market Y-o-Y Growth (%) by region, 2022-2028
Figure 13: North America mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 14: North America mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 15: North America mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2022
Figure 16: North America mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 17: North America mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 18: Latin America mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 19: Latin America mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 20: Latin America mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 21: Latin America mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 22: Latin America mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 23: Western Europe mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 24: Western Europe mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 25: Western Europe mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 26: Western Europe mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 27: Western Europe mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 28: Eastern Europe mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 29: Eastern Europe mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 30: Eastern Europe mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 31: Eastern Europe mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 32: Eastern Europe mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 33: Asia Pacific mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 34: Asia Pacific mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 35: Asia Pacific mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 36: Asia Pacific mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 37: Asia Pacific mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
Figure 38: Middle East & Africa mRNA Technology Market Size and Market Share Analysis (%) by Product, 2022 & 2028
Figure 39: Middle East & Africa mRNA Technology Market Size and Market Share Analysis (%) by Manufacturing, 2022 & 2028
Figure 40: Middle East & Africa mRNA Technology Market Size and Market Share Analysis (%) by Application, 2022 & 2028
Figure 41: Middle East & Africa mRNA Technology Market Size and Market Share Analysis (%) by End User, 2022 & 2028
Figure 42: Middle East & Africa mRNA Technology Market Size and Market Share Analysis (%) by Country, 2022 & 2028
List of Tables
Table 1: Global mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 2: Global mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 3: Global mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 4: Global mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 5: Global mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by region
Table 6: North America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 7: North America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 8: North America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 9: North America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 10: North America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 11: Latin America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 12: Latin America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 13: Latin America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 14: Latin America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 15: Latin America mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 16: Western Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 17: Western Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 18: Western Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 19: Western Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 20: Western Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 21: Eastern Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 22: Eastern Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 23: Eastern Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 24: Eastern Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 25: Eastern Europe mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 26: Asia Pacific mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 27: Asia Pacific mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 28: Asia Pacific mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 29: Asia Pacific mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 30: Asia Pacific mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
Table 31: Middle East & Africa mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Product
Table 32: Middle East & Africa mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Manufacturing
Table 33: Middle East & Africa mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Application
Table 34: Middle East & Africa mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by End User
Table 35: Middle East & Africa mRNA Technology Market Value (US$ Mn) Analysis and Forecast 2019-2028, by Country
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security